Proton-pump inhibitors are associated with increased cardiovascular risk independent of clopidogrel use: a nationwide cohort study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Controversy remains on whether the dual use of clopidogrel and proton-pump inhibitors (PPIs) affects clinical efficacy of clopidogrel.
OriginalsprogEngelsk
TidsskriftAnnals of Internal Medicine
Vol/bind153
Udgave nummer6
Sider (fra-til)378-86
Antal sider9
ISSN0003-4819
DOI
StatusUdgivet - 21 sep. 2010

ID: 34060502